SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-20-007154
Filing Date
2020-04-03
Accepted
2020-04-03 17:22:41
Documents
6
Period of Report
2020-05-26

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A nby20200401_pre14a.htm PRE 14A 591160
2 a1.jpg GRAPHIC 1124
3 graphic01.jpg GRAPHIC 16111
4 nby20200401_pre14aimg001.gif GRAPHIC 3999
5 nby20200401_pre14aimg002.jpg GRAPHIC 6187
6 sig1.jpg GRAPHIC 7968
  Complete submission text file 0001437749-20-007154.txt   641529
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33678 | Film No.: 20774692
SIC: 2834 Pharmaceutical Preparations